(Total Views: 95)
Posted On: 08/31/2023 12:45:52 PM
Post# of 27297

$NSPR News Article - InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at VIVA23 https://marketwirenews.com/news-releases/insp...83118.html


My Twitter: WhyteStocks